T2Bacteria Panel Wins CMS Approval For New Tech Add-On Payment

13 Aug 2019

• By Sue Darcey

The US Medicare agency approved a new technology add-on payment (NTAP) for T2 Biosystems’ blood test, the T2Bacteria panel, for the fiscal year that will begin on 1 October.

Array of blood samples for microscopy and biopsy tissue on blue gradient background

The US Centers for Medicare and Medicaid Services (CMS) recently agreed with diagnostic sponsor T2 Biosystems Inc. that the company’s T2Bacteria panel meets all of the agency’s qualifications for an additional new technology add-on payment (NTAP). It will apply the add-on payment starting in October.

After scrutinizing the sponsor’s application promoting an NTAP for the panel – which was developed to detect bacterial pathogens directly...